mRNA-3210

· ModernaTX, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for mRNA-3210, covering 2024-10-22 to 2024-10-22. Get the full timeline:

Most recent: Clinical Trial Update: A Dose-finding Study to Evaluate mRNA-3210 in Participants With Phenylketonuria [Phase 1, Phase 2]